Mario Caldararo

784 total citations
12 papers, 73 citations indexed

About

Mario Caldararo is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mario Caldararo has authored 12 papers receiving a total of 73 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Mario Caldararo's work include Cancer Immunotherapy and Biomarkers (3 papers), COVID-19 Clinical Research Studies (2 papers) and Infection Control and Ventilation (2 papers). Mario Caldararo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), COVID-19 Clinical Research Studies (2 papers) and Infection Control and Ventilation (2 papers). Mario Caldararo collaborates with scholars based in United States, Italy and Philippines. Mario Caldararo's co-authors include Charles S. Dela Cruz, Giuseppe Lippi, Jesus Alfonso Catahay, Anabel Franco‐Moreno, Jacqueline Veronica Velasco, César Fernández‐de‐las‐Peñas, Kin Israel Notarte, Brandon Michael Henry, Juan Torres‐Macho and Jennifer M. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, Infection Control and Hospital Epidemiology and Clinics in Chest Medicine.

In The Last Decade

Mario Caldararo

11 papers receiving 71 citations

Peers

Mario Caldararo
Mario Caldararo
Citations per year, relative to Mario Caldararo Mario Caldararo (= 1×) peers Birutė Zablockienė

Countries citing papers authored by Mario Caldararo

Since Specialization
Citations

This map shows the geographic impact of Mario Caldararo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Caldararo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Caldararo more than expected).

Fields of papers citing papers by Mario Caldararo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Caldararo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Caldararo. The network helps show where Mario Caldararo may publish in the future.

Co-authorship network of co-authors of Mario Caldararo

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Caldararo. A scholar is included among the top collaborators of Mario Caldararo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Caldararo. Mario Caldararo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Fernández‐de‐las‐Peñas, César, Juan Torres‐Macho, Jesus Alfonso Catahay, et al.. (2024). Correction: Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review. Infection. 52(5). 1687–1687. 1 indexed citations
2.
Patel, Chirag, et al.. (2024). Calcium Chaos in Sarcoidosis: A Tale of Severe Hypercalcemia's Diagnostic Challenge. Cureus. 16(3). e56271–e56271. 1 indexed citations
3.
Caldararo, Mario, et al.. (2023). The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections. Clinics in Chest Medicine. 44(2). 407–423. 19 indexed citations
5.
Fernández‐de‐las‐Peñas, César, Juan Torres‐Macho, Jesus Alfonso Catahay, et al.. (2023). Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review. Infection. 52(1). 43–58. 23 indexed citations
6.
Caldararo, Mario, Elizabeth Schmidt, Ioannis Politikos, et al.. (2022). Atypical Pathogens Presenting With Pulmonary Consolidations Detected by Cell-Free DNA Next-Generation Sequencing in Patients With Hematologic Malignancies. Infectious Diseases in Clinical Practice. 30(2). 4 indexed citations
7.
Babady, N. Esther, Bevin Cohen, Mario Caldararo, et al.. (2021). Variable duration of viral shedding in cancer patients with coronavirus disease 2019 (COVID-19). Infection Control and Hospital Epidemiology. 43(10). 1413–1415. 11 indexed citations
9.
Caldararo, Mario, Sheel Patel, Sharon Li, et al.. (2018). Effect of pretreatment steroids on the development of immune related adverse events.. Journal of Clinical Oncology. 36(15_suppl). e15095–e15095. 3 indexed citations
10.
Li, Sharon, Sheel Patel, Mario Caldararo, et al.. (2018). Impact of age on immune checkpoint blockade tolerability across malignancies: A single institution review.. Journal of Clinical Oncology. 36(15_suppl). e15069–e15069.
11.
Clark-Garvey, Sean, Sheel Patel, Sharon Li, et al.. (2018). Impact of comorbidity on immune checkpoint blockade tolerance across tumor types.. Journal of Clinical Oncology. 36(15_suppl). e15068–e15068. 3 indexed citations
12.
Caldararo, Mario, et al.. (2018). New case of krokodil (desomorphine) use. International Journal of Case Reports and Images. 9. 1–1. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026